Ledger.Open graph →
SEC Form D · filed March 12, 2018

NSC Biotech Opportunities Fund, LLC

Offering
$30.0M
Sold
$1.1M
Exemption
Rule 506(b)
Industry
Pooled Investment Fund
Location
NEW YORK, NY
Type
Pooled fund

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Michael Mullen · New York, NYDirectorTom Kowalczyk · New York, NYDirectorGlenn Worman · New York, NYDirectorNsc Biotech Opportunities Management Associates, Llc · New York, NYDirectorDavid Shippy · Austin, TXDirectorTiffany Devitt · Santa Rosa, CADirectorJack B. Strommen · El Segundo, CADirectorTracy Weaver · Dallas, TXDirectorJohn Larson · Dallas, TXDirectorAlan Aspuru-Guzik · Cambridge, MADirectorNsc Biotech Opportunities Management Associates, Llc · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗